However it’s our case, so the Reed Smith side can’t comment on it … period. Maybe the Dechert side will. All we can do at this time is provide our readers with a link to the opinion.
The definitive source for intelligent commentary on the law that matters for drug and device product liability cases
However it’s our case, so the Reed Smith side can’t comment on it … period. Maybe the Dechert side will. All we can do at this time is provide our readers with a link to the opinion.